Bionomics Limited : BNC105 RENAL CANCER TRIAL DATA PRESENTED AT ASCO-GU - 4-traders (press release) |
4-traders (press release)
Bionomics Limited (ASX: BNO) (ADR: BMICY) announced that BNC105 clinical trial data in patients with progressive metastatic renal cancer will be presented at the American Society for Clinical Oncology 2012 Genitourinary Cancers Symposium meeting
|
Leak forces closures at Dalhousie health centre - CBC.ca |
CBC.ca
(Restigouche Health Authority) A broken water pipe at the St. Joseph Community Health Centre in Dalhousie has forced the temporary closure of its satellite dialysis unit and satellite palliative care unit. The leak was detected Thursday morning and
|
New Oral Kinase Inhibitor Axitinib Approved for Advanced Renal Cancer - Pharmacy Practice News |
Medicare Pay Policy on Transplant Drugs Slammed - MedPage Today |
MedPage Today
The policy forces many patients to give up anti-rejection drugs, leading to graft failure and a return to dialysis, according to John S. Gill, MD, of the University of British Columbia in Vancouver, and Marcello Tonelli, MD, of the University of
|